Sambhara S - Search Results

1

Improving immunogenicity and effectiveness of influenza vaccine in older adults.

Cao W, Kim JH, Chirkova T, Reber AJ, Biber R, Shay DK, Sambhara S. Cao W, et al. Among authors: sambhara s. Expert Rev Vaccines. 2011 Nov;10(11):1529-37. doi: 10.1586/erv.11.137. Expert Rev Vaccines. 2011. PMID: 22043953 Review.

2

Immunity to influenza: the challenges of protecting an aging population.

Katz JM, Plowden J, Renshaw-Hoelscher M, Lu X, Tumpey TM, Sambhara S. Katz JM, et al. Among authors: sambhara s. Immunol Res. 2004;29(1-3):113-24. doi: 10.1385/IR:29:1-3:113. Immunol Res. 2004. PMID: 15181275 Review.

3

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

Hoelscher MA, Garg S, Bangari DS, Belser JA, Lu X, Stephenson I, Bright RA, Katz JM, Mittal SK, Sambhara S. Hoelscher MA, et al. Among authors: sambhara s. Lancet. 2006 Feb 11;367(9509):475-81. doi: 10.1016/S0140-6736(06)68076-8. Lancet. 2006. PMID: 16473124 Free PMC article.

4

Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.

Garg S, Hoelscher M, Belser JA, Wang C, Jayashankar L, Guo Z, Durland RH, Katz JM, Sambhara S. Garg S, et al. Among authors: sambhara s. Clin Vaccine Immunol. 2007 Jul;14(7):926-8. doi: 10.1128/CVI.00450-06. Epub 2007 May 9. Clin Vaccine Immunol. 2007. PMID: 17494637 Free PMC article.

5

Breaking the immunogenicity barrier of bird flu vaccines.

Sambhara S, Poland GA. Sambhara S, et al. Lancet. 2007 Aug 18;370(9587):544-5. doi: 10.1016/S0140-6736(07)61269-0. Lancet. 2007. PMID: 17707733 No abstract available.

6

New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.

Hoelscher MA, Jayashankar L, Garg S, Veguilla V, Lu X, Singh N, Katz JM, Mittal SK, Sambhara S. Hoelscher MA, et al. Among authors: sambhara s. Clin Pharmacol Ther. 2007 Dec;82(6):665-71. doi: 10.1038/sj.clpt.6100418. Epub 2007 Oct 24. Clin Pharmacol Ther. 2007. PMID: 17957181 Free PMC article.

7

A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

Hoelscher MA, Singh N, Garg S, Jayashankar L, Veguilla V, Pandey A, Matsuoka Y, Katz JM, Donis R, Mittal SK, Sambhara S. Hoelscher MA, et al. Among authors: sambhara s. J Infect Dis. 2008 Apr 15;197(8):1185-8. doi: 10.1086/529522. J Infect Dis. 2008. PMID: 18462165 Free PMC article.

8

Vaccines against epidemic and pandemic influenza.

Hoelscher M, Gangappa S, Zhong W, Jayashankar L, Sambhara S. Hoelscher M, et al. Among authors: sambhara s. Expert Opin Drug Deliv. 2008 Oct;5(10):1139-57. doi: 10.1517/17425247.5.10.1139. Expert Opin Drug Deliv. 2008. PMID: 18817518 Review.

9

Moving influenza vaccines forward.

Sambhara S, Stephenson I. Sambhara S, et al. Expert Rev Vaccines. 2009 Apr;8(4):375-7. doi: 10.1586/erv.09.10. Expert Rev Vaccines. 2009. PMID: 19348553 Free article. No abstract available.

10

Immunosenescence and influenza vaccine efficacy.

Sambhara S, McElhaney JE. Sambhara S, et al. Curr Top Microbiol Immunol. 2009;333:413-29. doi: 10.1007/978-3-540-92165-3_20. Curr Top Microbiol Immunol. 2009. PMID: 19768417 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page